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Objectives: to evaluate an alternative and simple technique which consists in impregnation of a synthetic prosthesis
with either autogenic omental fat or bone marrow. These tissues have been selected based on previous works and
because they contain multiple cellular and extracellular compounds with biological healing properties (i.e. angiogenesis,
endothelialisation, etc.).
Design: PTFE grafts of Group 1 were impregnated with fatty tissue, those of Group 2 with bone marrow and those of
Group 3 served as controls.
Materials: nine mongrel dogs divided among these three groups. PTFE grafts are 3 mm in diameter.
Methods: in each animal, both iliac arteries were submitted to an end-to-side ilio-iliac bypass. At 3 months, pathology
assessment was performed.
Results: group 1: all grafts were thrombosed and intimal hyperplasia was found occluding the anastomotic sites. Group
2: 4/6 grafts were patent and their mid-portion presented a thin neointima which did not totally cover the anastomotic
sites. Group 3: 2/5 grafts were patent and their mid-portion as well as the anastomotic sites were covered with neointima
which was hyperplastic in some areas.
Conclusions: addition of bone marrow cells may contribute to improve the quality of the healing process.
Key Words: Vascular prosthesis; Small diameter vessel replacement; Bone-marrow; PTFE, Omental tissue; Healing.
Introduction inconsistent and unpredictable.13,14 The isolation of a
large number of endothelial cells and the cultures of
Clinical use of small-calibre synthetic arterial grafts endothelial cells are required for lining grafts with
has shown lower patency rate than that of autologous cells prior to surgery. Therefore, the use of these
arteries1 or saphenous vein.2 The two major causal techniques is restricted.15–17
factors are (i) enhanced thrombogenicity of the syn- Recently, autologous tissue fragments, including
thetic material due to reduced flow through these omental or subcutaneous cells, vein fragments or bone
small-calibre grafts, and (ii) development of intimal marrow cells have been proposed as alternative bio-
hyperplasia particularly at the anastomoses, leading logical materials.18–22 Preliminary results with tissue
to late obstruction and thrombosis.3–5 fragments-impregnated polyester prostheses were
Graft seeding techniques using endothelial cells promising with improved endothelialisation, and de-
have been proposed to overcome the thrombogenic creased myointimal proliferation with subsequent
properties of synthetic luminal surfaces of small-dia- long-term patency. Fatty tissue contains numerous
meter vascular prostheses. Several methods of endo- capillaries. It is postulated that capillary-derived endo-
thelialisation have been offered, like direct seeding or thelial cells will promote angiogenesis within graft
sodding of endothelial cells within synthetic graft.6–9 wall.21 In bone marrow, stem cells can differentiate
However, results showed poor endothelial cell re- into endothelial cells,23 and enhance endothelial cell
tention under blood-flow stress.10 Experimental graft lining by the release of cytokines.20,21 Moreover, use of
impregnation with adhesive molecules (i.e. oligo- these materials seems to present other advantages
peptides or glycoproteins) appeared to improve endo- such as rapid availability, without expensive and time-
thelial cell retention.11,12 However, clinical results were consuming endothelial cell isolation and culture.
The technology involving the use of autologous
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Biomateriaux E0-178, 10, rue de l’Espinay, Quebec, G1L 3L5, Canada. fluence the future of small-diameter prostheses (i.e.
1078–5884/99/100308+07 $12.00/0 Ó 1999 Harcourt Publishers Ltd.
Fat- and Bone Marrow-impregnated PTFE Grafts 309
2–3-mm diameter). In addition, end-to-side ana- 0.5 g of fatty tissue was collected from the omentum
and inserted in a 3-ml syringe. Another syringe wasstomoses which reproduce the clinical reality more
adequately than end-to-end anastomoses should prob- filled with 2 ml of culture medium (Dulbecco’s
Modified Eagle’s Medium, DMEM, Sigma Chemicalably be preferred in such experiments.24,25 In the present
study, the effect of omental fat emulsion and that of Co., St Louis, MO, U.S.A.) containing 90 lg heparin
and connected to a 3-way valve to which was alsobone-marrow cell seeding have been compared in a
canine iliac artery bypass model. fixed the syringe containing fatty tissue.
Homogenisation of the fatty tissue was obtained by
alternately passing the content of one syringe intoMaterials and Methods
the other while gradually closing the valve. The
homogenate was then injected under manualTechnique of graft implantation
pressure (syringe piston) into a 7-cm segment of the
Surgery was performed under sterile conditions on PTFE graft, one end of which had been ligated.
nine adult mongrel dogs weighing within 16 and 28 kg. Sufficient pressure was exerted so as to visualise the
The experiments were conducted according to the appearance of some of the homogenate on the
guidelines of the Canadian Council for Animal Care external surface of the whole graft. At this stage,
and after approval by the Local Institutional Animal graft impregnation was considered valid. The graft
Care Committee. Each dog received daily 160 mg of was then extensively irrigated with culture medium
acetylsalicylic acid orally 48 hours before the surgery to remove non-adherent fatty tissue. The graft was
and for the following 30 days. The animals were then implanted.
anaesthetised with ketamine and ventilated with a
mixture of oxygen and isoflurane. Heparin was in- Group 2 (bone marrow cells)
jected as a bolus (100 I.U./kg) given before the arterial Bone marrow was retrieved from the iliac bone with
clamping followed by a continuous perfusion (40 I.U./ a paediatric puncture needle previously rinsed with a
kg/h) during surgery. citrate solution. One ml of bone marrow suspension
The graft (W.L. Gore & Associates, Flagstaff, AZ, was then injected into the graft according to a tech-
U.S.A.) was a 5-cm straight tube with a 3-mm diameter. nique similar to that described for Group 1. The graft
Its internodal distance was 30 lm. The proximal ana- was then implanted.
stomosis (end-to-side) was performed on the iliac ar-
Group 3 (control)tery at the level of the aortic trifurcation. The distal
PTFE grafts were soaked in DMEM containing heparinanastomosis (end-to-side) was done 5-cm distal to the
for 5 minutes prior to implantation.first one. A running suture was done with 7-0 PTFE
monofilament (W. L. Gore & Associates, Flagstaff, AZ,
U.S.A.). The iliac artery was ligated between the sites
Scanning electron microscopy (SEM)of the anastomoses using a polypropylene thread. Both
right and left iliac arteries were bypassed in each dog.
Prior to implantation, short segments of impregnatedDogs were randomly divided into 3 groups. In
grafts were proceeded with for SEM. At sacrifice,Group 1, fragments of autogenic omental fat were
samples from patent grafts were also retrieved forused to impregnate grafts prior to implantation. In
SEM observation. Samples for SEM were fixed inGroup 2, autogenic bone-marrow cells were used to
2.5% glutaraldehyde solution (in phosphate-bufferedimpregnate grafts. In the Third Group (control group),
solution, PBS) and washed in cacodylate buffer (0.1 Mthe grafts were not impregnated with biological ma-
in PBS). After dehydration with increasing con-terial. Each dog received two similarly treated pros-
centrations of ethanol, samples were immersed intheses in order to avoid any paracrine or juxtacrine
hexamethyldisilazane (Polysciences Inc., PA, U.S.A.).phenomena that could be highly involved if we had
Once dried, samples were sputter-coated. Samplesused two different grafts in the same animal. After a
were observed using a Jeol 35CF scanning electronthree-month period, the animals were sacrificed and
microscope at 15 kV.the grafts were submitted to macroscopic and micro-
scopic evaluations.
Graft preparation Doppler imaging
Group 1 (omental fat) Peak velocities at different levels (aorta, proximal and
distal anastomoses, inside the graft, distal to the graft)During surgery and before arterial clamping, about
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were measured (image point Doppler ultrasound sys-
tem, HP Sonos, Hewlett Packard, Toronto, Canada)
immediately and at 1, 2 and 3 months after surgery.
Graft explantation and histologic analysis
Under anaesthesia, dogs were sacrificed 3 months after
surgery. Prior to sacrifice, 5000 I.U. of heparin were
administered intravenously and the animal was ex-
sanguinated. The aorta and the common iliac arteries
and the grafts were excised and fixed in a 4% fresh
paraformaldehyde solution (in PBS at pH 7.2). Gross
examination was performed. Explanted grafts were
cut in three segments: (i) proximal anastomotic site,
(ii) mid-part of the prosthesis, and (iii) distal an-
astomotic site. Anastomotic sites included portions of
the native vessels. Fixed tissue specimens were then
processed for serial histological sections (every
150–200 lm) transversally to the axis of the ana-
stomoses (proximal and distal) or the prostheses
(middle). Serial tissue sections were stained by Hema-
toxylin Phloxin Saffron and double stained by Mas-
son’s trichrome and Weigert. Using an image analysis
system (NIH Image, Bethesda, MA, U.S.A.), the lu-
minal surface area was measured on each serial tissue
section in the mid-portion of patent prostheses. The
surface area measurements were respectively reported
to those occupied by the lumen of the PTFE itself. This
ratio was considered as the relative degree of stenosis
observed on patent grafts.
Results
Scanning electron microscopy
Before implantation, fat-impregnated PTFE grafts
(Group 1) were partially covered with a thin layer of
biological material (Fig. 1). Bone-marrow-impregnated
grafts (Group 2) were totally covered with numerous
cells and a biological film. By 3 months (Fig. 1C),
endothelial cells were present on the whole surface of
the luminal surface of patent bypasses in Group 2, Fig. 1. Scanning electron micrographs of PTFE prostheses im-
and in some areas in Group 3. pregnated with omental tissue (A: ·100), and bone marrow (B:
·480) prior to vascular implantation, and bone marrow 3 months
after implantation (C: ·600).
294 cm/s) compared to those found in the aortaDoppler results
(99.7–28.4 cm/s). In Group 1, four out of the six grafts
exhibited stenosis at mid-portion by 1 month and wereImmediately after surgery, Doppler imaging showed
all grafts to be patent. Because of the small graft occluded by 2 months, while the remainder presented
a proximal stenosis with a slight distal stenosis. Thediameter, velocity values were high (average of
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two latter stenoses became subtotal by 3 months. In smooth-muscle cells (i.e. hyperplasia) was seen at the
level of one proximal and one distal anastomosis, atGroup 2, four out of the six grafts appeared normal
while the other two showed moderate proximal sten- the toe of one proximal and one distal anastomosis;
and at the floor of one proximal anastomosis. Theosis by 1 month for one and occlusion by 2 and 3
months for the others. In Group 3, occlusion was found mid-portions of the patent grafts of Group 2 were
completely covered with neointima of moderate thick-in one case by 2 months; subtotal stenoses were found
at the proximal anastomoses in three grafts by 1 month ness (Figs 2 and 3) which reduced luminal surface by
26.9–3.4%. Neointima had a smooth surface coveredwhich were found occluded by 3 months; two grafts
appeared normal at the end of the observational with endothelial cell lining. Endothelial cells were
positive for factor VIII-related antigen as observedperiod.
by immunohistochemistry. In addition, the neointima
seemed to tightly bind the PTFE internal surface.
Conversely, in the patent grafts (2/5) of the control
Macroscopy group (Group 3), neointima with endothelial-shape-
like cells was found at the proximal and distal an-
In Group 1, all grafts were occluded at 3 months by astomotic sites. However, the neointima, which did
a dense fibrotic tissue with an old thrombus. In Group not exceed 30 lm in thickness, was limited to an area
2, four grafts were patent, one presented a moderate close to the suture line in most cases, and did not
stenosis, and the other was occluded. In Group 3, one extend away from the anastomotic sites. The rest of
prosthesis was infected and therefore eliminated from the anastomoses were devoid of endothelial cells or
the study. One graft was normal and the other mod- neointima. Concerning hyperplasia at the anastomotic
erately stenotic; the other three grafts were occluded sites, it was observed at the heel and at the toe of two
by old thrombus with some fibrotic tissue. proximal and of one distal anastomotic site, and at the
floor of one proximal and of one distal anastomotic
site. At the mid-point of the graft, thick neointima was
found with endothelial-shape-like cells (factor VIII-
Histology positive cells) in one graft, and in another case the
PTFE graft was covered with a thin layer of blood
Occluded grafts of all groups exhibited the same path- (Figs 2 and 3) with no endothelial cell lining. The
ology. The proximal anastomoses were occluded by a average of the luminal surface was reduced by
highly vascularised fibrotic tissue (Fig. 2) and, as serial 13.4–0.8% at mid-portion of the patent grafts of Group
tissue sections were away from the proximal an- 3.
astomotic sites, old thrombus was present. In a few
cases, occluding fibrotic tissue was observed at the
anastomotic sites without clot formation. At the mid-
portion of the prostheses, thrombi filled the lumens Discussion
(Fig. 2), except in one case in Group 1, one case in
Group 2 and two cases in the control group. In those Efforts to bring small diameter vascular prostheses to
clinical use have focused on luminal cell lining inlatter conditions, the lumens were found patent at mid-
portion with no endothelial cell lining or formation of order to obtain a biological barrier to thrombus for-
mation and intimal hyperplasia. Among polymersnew tissue on the inner surface of the grafts (i.e.
neointima). At the distal anastomotic sites of these used to produce small-diameter prosthesis, PTFE
seems to offer optimal biomechanical and haemo-occluded grafts, both fibrotic tissue and thrombus
occluded the lumen in all the groups. compatible properties. PTFE-impregnation with bone-
marrow cells or fatty tissue could be an alternative toIn the four patent grafts of Group 2, a new layer
of tissue (i.e. neointima) inconsistently covered the direct endothelial-cell seeding or sodding. We felt it
important from a clinical point of view to performluminal surface of the proximal and distal anastomotic
sites (Figs 2 and 3). Endothelial shape-like cells were end-to-side anastomoses which present stressful
haemodynamic conditions,24 and since this type oflining the neointima. In the areas free from neointima,
the luminal surface of the PTFE graft remained un- anastomosis is preferentially used in peripheral and
coronary bypass surgery.coated. Neointima covered predominantly the surface
of the prostheses away from the distal or proximal Following implantation in our canine model, PTFE
grafts impregnated with omental fat led to rapid oc-anastomoses, when compared to that of the an-
astomotic sites. Neointima containing proliferative clusion by fibrotic tissue. Conversely, bone marrow
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Fig. 2. Serial tissue sections of PTFE grafts after 90 days. Grafts were either untreated (A & B), impregnated with fatty tissue (C & D) or
bone marrow (E & F). Tissue sections derived from the mid-portion of the grafts (A, C & E) and from the distal anastomoses (B, D & F).
In Groups 2 (bone marrow) and 3 (control), sections from patent prostheses are shown. Note the presence of thrombus in C and fibrotic
tissue filling the graft at the anastomotic sites in D (Group 1). In occluded grafts of Group 2 (2/6) and Group 3 (4/6) similar observations
as in C & D were seen. (·10).
impregnation of the grafts appeared to improve the to intraluminal growth of omental tissue but this was
not substantiated by histology. However, thrombo-quality of the healing process. Specifically, the healing
pattern resulted in a smooth covering of the luminal genicity of the homogenate is significant since Group
1 demonstrated no graft patency by 3 months, a resultsurface by endothelial cells as demonstrated by the
presence of factor VIII. Decreased thrombogenicity inferior to that of the control group. Grafts’ im-
pregnation with fatty tissue might be more appropriatecould be consequently expected in 66% of the grafts
of Group 2. Non-impregnated grafts of Group 3 were for porous grafts as reported by Noishiki and col-
leagues18,22 using Dacron or high-porosity PTFE, prob-expected to be thrombogenic. However, the small num-
bers of animals in each group suggests caution in ably due to wound tissue ingrowth. However, Dacron
prostheses are not available in small diameterinterpretation of the results.
In our experience, fatty tissue failed to improve (Z3 mm), and high-porosity (i.e., 90 lm) PTFEs are
subjected to dilation and rupture. On the other hand,patency of the 3-mm PTFE grafts. This could be due
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on the luminal surface. By histological assessment, this
neointima consisted of a dense fibrotic tissue with
no sign of a hyperplastic process which is observed,
however, in the patent grafts of the control group. A
recent study using in situ hybridisation demonstrates
the absence of PDGF expression in this neointima
(personal communication). This suggests that bone-
marrow cells could enhance the wound-healing pro-
cess. Newly formed tissue is rapidly laid down onto
the surface of this synthetic material. On the other
hand, the anastomotic sites, and more specifically the
distal site, were exposed to critical haemodynamic
stress with increased risks for hyperplasia de-
velopment.27 In our end-to-side model, no hyperplasia
was seen at the floor of the recipient artery at the
distal site in Group 2, and minimal hyperplasia at the
heel in Group 2, compared to that found in the control
group. PTFE grafts at the anastomotic sites showed
partial coverage with neointima compared to that seen
in the middle part of the graft itself. This phenomenon
might be due to (i) surgical manipulations during the
impregnation and/or suture phases that could induce
detachment of marrow cells; and (ii) haemodynamic
stresses induced by an end-to-side anastomosis. Our
findings observed in Group 2 with an end-to-side
anastomosis are close to those of Noishiki et al.21 who
observed a decrease in myointimal hyperplasia after
implantation of bone-marrow-impregnated grafts in
end-to-end anastomoses. Although 40% of the grafts
were patent in the control group at 3 months, one
could expect occlusion to occur in the rather near
future since the original thrombogenicity of the graft
had not been altered.
Fall out endothelialisation has been shown to occur
in human.28,29 More recently, Shi et al.23 have clearly
shown that endothelial cells lining a vascular pros-
thesis can be derived from the marrow because a
subset of bone-marrow cells have the ability to dif-
ferentiate into endothelial cells. On the other hand,
reduction in progression of intimal hyperplasia may
Fig. 3. Histologic sections of patent grafts. In patent grafts (2/6) of
be achieved if a stable endothelial-cell lining can beGroup 3 (control), the luminal surface of the graft was irregularly
covered by a thin layer, mostly composed of blood elements with formed close to or at the time of graft implantation.30
some foci of hyperplasia (A). In patent grafts (4/6) of Group 2 (bone In bone-marrow-impregnated grafts, the rapid re-
marrow), neointima covered the whole surface at mid-portion (B)
endothelialisation by implanted marrow cells mayand partially at the anastomotic sites (C). (·30).
reduce the usually seen intimal smooth-muscle cells.
In contrast to endothelial-cell seeding that needscontrolled enzyme digestion of fatty or omental tissues
extensive preoperative preparation in terms of cellas previously reported8,26 is an avenue which could be
culture and in terms of graft preparation using ad-further explored. However, the technique is complex,
hesive peptides or protein coating, acceleration of theand time-consuming.
vascular healing process could be achieved by directlyIn our study, the results obtained in Group 2 (bone
introducing bone-marrow cells into the microstructuremarrow) exhibit interesting features. Although the
of PTFE. The technique of impregnation of autologouslumen in patent grafts was reduced compared to that
of Group 3, the neointima was uniformly distributed tissues, more specifically bone marrow, that we used
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substrate and surface configuration determine adherence andand which was originally reported by Noishiki and
spreading of seeded endothelial cells on polytetrafluoroethylene
colleagues, could easily be performed during surgery. grafts. J Vasc Surg 1989; 9: 535–541.
13 Dunn PF, Newman KD, Jones M et al. Seeding of vascularThis is an additional advantage compared to other
grafts with genetically modified endothelial cells. Secretion ofalternatives. Refinement of the technique, such as in-
recombinant TPA results in decreased seeded cell retention in
troducing bone-marrow cells into the microstructure vitro and in vivo. Circulation 1996; 93: 1439–1446.
14 Herring M, Smith J, Dalsing M et al. Endothelial seeding ofof PTFE, could further improve the graft patency rate
polytetrafluoroethylene femoral popliteal bypasses: The failurecompared to virgin PTFE grafts. A larger number of
of low-density seeding to improve patency. J Vasc Surg 1994; 20:
animals and implanted grafts would be necessary in 650–655.
15 Zilla P, Deutch M, Meinhart J et al. Clinical in vivo endo-order to statistically validate our results.
thelialisation of femoropopliteal bypass grafts: An actuarial fol-
low-up over three years. J Vasc Surg 1994; 19: 540–548.
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